Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Other Non-Current Liabilities (2020 - 2026)

Oric Pharmaceuticals filings provide 7 years of Other Non-Current Liabilities readings, the most recent being $3.4 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 37.6% to $3.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Mar 2026, down 37.6% year-over-year, with the annual reading at $4.1 million for FY2025, 33.41% down from the prior year.
  • Other Non-Current Liabilities hit $3.4 million in Q1 2026 for Oric Pharmaceuticals, down from $4.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $10.3 million in Q2 2022 and bottomed at $3.4 million in Q1 2026.
  • Average Other Non-Current Liabilities over 5 years is $7.2 million, with a median of $7.0 million recorded in 2024.
  • The largest annual shift saw Other Non-Current Liabilities surged 4764.11% in 2022 before it plummeted 40.04% in 2025.
  • Oric Pharmaceuticals' Other Non-Current Liabilities stood at $9.4 million in 2022, then fell by 20.96% to $7.5 million in 2023, then fell by 17.25% to $6.2 million in 2024, then crashed by 33.41% to $4.1 million in 2025, then decreased by 16.47% to $3.4 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Other Non-Current Liabilities are $3.4 million (Q1 2026), $4.1 million (Q4 2025), and $4.1 million (Q3 2025).